Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
-
1141
Eligibility criteria.
Published 2024“…Data will be collected and synthesized for seven pre-specified outcomes at 6 weeks and 3 months following surgery: i) change in central retinal thickness measured by optical coherence tomography (OCT), ii) best-recorded visual acuity iii) the rate of CME measured by OCT, and fluorescein angiography (FA) iv) the rate of patients experiencing clinically significant macular edema defined as the presence of CME and pre-specified thresholds for decreased visual acuity, v) patient quality of life, vi) intraocular pressure and vii) the number of patients experiencing one or more pre-specified adverse events. …”
-
1142
Flowchart of the clinical trial.
Published 2025“…The clinical trial’s results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels. …”
-
1143
Plant Extracellular Nanovesicle-Loaded Hydrogel for Topical Antibacterial Wound Healing <i>In Vivo</i>
Published 2024“…Bacterial infections impede wound healing and pose significant challenges in clinical care. There is an immediate need for safe and targeted antivirulence agents to fight bacterial infections effectively. …”
-
1144
Plant Extracellular Nanovesicle-Loaded Hydrogel for Topical Antibacterial Wound Healing <i>In Vivo</i>
Published 2024“…Bacterial infections impede wound healing and pose significant challenges in clinical care. There is an immediate need for safe and targeted antivirulence agents to fight bacterial infections effectively. …”
-
1145
Trend of total hospital attendance.
Published 2024“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
-
1146
Trend of outpatient (OPD) consultations.
Published 2024“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
-
1147
Variables used for the analysis.
Published 2024“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
-
1148
Trend of PNC attendance over the period.
Published 2024“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
-
1149
Trend of ANC attendance over the period.
Published 2024“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
-
1150
Total hospital attendances by specialty.
Published 2024“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
-
1151
-
1152
Baseline characteristics of the study sample<sup>β</sup>μ.
Published 2024“…<div><p>Background</p><p>Drug-related problems (DRPs) significantly threaten the safety of the elderly. In order to improve pharmacists’ ability to minimize these events, novel educational interventions that consider the current challenges in clinical practice are crucial.…”
-
1153
The flow diagram of the study (CONSORT, 2010).
Published 2024“…<div><p>Background</p><p>Drug-related problems (DRPs) significantly threaten the safety of the elderly. In order to improve pharmacists’ ability to minimize these events, novel educational interventions that consider the current challenges in clinical practice are crucial.…”
-
1154
Forest plot for clinical efficacy.
Published 2025“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”
-
1155
-
1156
-
1157
Data analysed during this study.
Published 2025“…In contrast, beta diversity analysis, assessed through Bray-Curtis dissimilarity, revealed significant differences in microbial composition between pre- and post-treatment samples. …”
-
1158
Baseline analysis, nominal factors.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
-
1159
Minimal dataset for the study.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
-
1160
Baseline analysis, continuous factors.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”